Abstract
Dopamine receptor blocking agents may cause tardive dyskinesia and, because of this risk, only carefully selected patients should be given these agents. Although atypical antipsychotics are less likely to cause tardive dyskinesia than typical agents, the risk remains. When switching or withdrawing a dopamine receptor blocking agent, the dose should be tapered slowly. The preferred drug for treating patients with moderate to severe tardive dyskinesia is the dopamine-depleting agent tetrabenazine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.